ZEN, spelled Z-E-N, stands as the umbrella and holding entity for ZENAI, LUX, Note Enterprise Payments and the recently released ZEN Halo. Crafting a niche in the software-as-a-service (SaaS) and business consulting realms through blockchain innovation. At the core of ZEN’s offerings is Lux AI, a firm dedicated to empowering small to medium-sized businesses by integrating a proprietary financial ecosystem that bypasses traditional third-party solutions like PayPal, Cash App, and major credit card services.
Meet Sahaj, AI Curriculum, Governance & Ethics Officer at ZEN:
‘Hello! I’m Sahaj, a passionate PhD researcher delving into the intricate realms of AI governance and policy making within the healthcare sector. My work spans various impactful projects, each driven by a commitment to addressing the evolving challenges and opportunities in this dynamic field. Projects: IEEE SA AI Project – Patient-Centric Solutions: I’m actively contributing to a collaborative project with IEEE SA, where the focus is on designing AI-based solutions with a central emphasis on patients within the healthcare ecosystem. Our goal is to provide innovative interventions that facilitate seamless treatment experiences and ensure rapid access to healthcare services. Ethical AI in Healthcare – Regulatory Framework: Leading a project that explores the nuanced challenges and opportunities associated with incorporating ethical AI in healthcare settings. We’re proposing a quadrant-based regulatory framework that takes a holistic approach, ensuring the ethical deployment of AI. This framework is designed to strike a balance between innovation, patient safety, privacy, and transparency. Role at Atraxel – US-Based Startup: In my capacity at Atraxel, a healthcare startup based in the United States, I play a crucial role in devising AI solutions tailored for individuals with Type I diabetes. I’m responsible for formulating strategies and roadmap planning to guide the company in the responsible adoption of AI technologies. It’s an exciting journey as we work towards developing AI-driven solutions that significantly impact the lives of those managing Type I diabetes. My multidimensional involvement in these projects reflects my dedication to advancing the responsible and ethical integration of AI in healthcare. Through my research and contributions, I aim to shape the future landscape of healthcare policies, governance, and innovative AI solutions, making a profound impact on the well-being of patients.’
